SRG Fundamental Analysis - SERITAGE GROWTH PROP- A

Name: SERITAGE GROWTH PROP- A (SRG) Stock
Brand: SERITAGE GROWTH PROP- A
Rating: 5 (3 reviews)

Fundamental Rating

SRG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. SRG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SRG does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

SRG had negative earnings in the past year.

In the past year SRG has reported a negative cash flow from operations.

In the past 5 years SRG always reported negative net income.

In the past 5 years SRG always reported negative operating cash flow.

1.2 Ratios

SRG has a Return On Assets of -15.45%. This is in the lower half of the industry: SRG underperforms 75.00% of its industry peers.

The Return On Equity of SRG (-25.31%) is worse than 65.63% of its industry peers.

		Industry Rank	Sector Rank
ROA	-15.45%
ROE	-25.31%
ROIC	N/A

ROA(3y)-14.69%

ROA(5y)-9.92%

ROE(3y)-26.18%

ROE(5y)-20.06%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SRG so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SRG does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, SRG has about the same amount of shares outstanding.

SRG has more shares outstanding than it did 5 years ago.

The debt/assets ratio for SRG has been reduced compared to a year ago.

2.2 Solvency

SRG has an Altman-Z score of -2.00. This is a bad value and indicates that SRG is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of SRG (-2.00) is worse than 81.25% of its industry peers.

SRG has a Debt/Equity ratio of 0.57. This is a neutral value indicating SRG is somewhat dependend on debt financing.

SRG has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.57
Debt/FCF	N/A
Altman-Z	-2

ROIC/WACCN/A

WACC9.33%

2.3 Liquidity

SRG has a Current Ratio of 3.60. This indicates that SRG is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 3.60, SRG belongs to the best of the industry, outperforming 82.81% of the companies in the same industry.

SRG has a Quick Ratio of 3.60. This indicates that SRG is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 3.60, SRG belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.6
Quick Ratio	3.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.41%, which is quite impressive.

Looking at the last year, SRG shows a very negative growth in Revenue. The Revenue has decreased by -30.25% in the last year.

SRG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.34% yearly.

EPS 1Y (TTM)27.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%71.01%

Revenue 1Y (TTM)-30.25%

Revenue growth 3Y-46.75%

Revenue growth 5Y-36.34%

Sales Q2Q%10.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SRG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SRG does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SERITAGE GROWTH PROP- A

NYSE:SRG (10/29/2025, 8:04:01 PM)

After market: 4.07 0 (0%)

4.07

-0.06 (-1.45%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)08-12 2025-08-12

Earnings (Next)11-10 2025-11-10

Inst Owners44.96%

Inst Owner Change-0.79%

Ins Owners13.09%

Ins Owner Change0%

Market Cap229.22M

Revenue(TTM)16.89M

Net Income(TTM)-88932000

Analysts80

Price Target6.63 (62.9%)

Short Float %14.21%

Short Ratio37.16

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.09

Dividend Growth(5Y)-32.24%

DP-5.51%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-23.53%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	13.58
P/FCF	N/A
P/OCF	N/A
P/B	0.65
P/tB	0.65
EV/EBITDA	N/A

EPS(TTM)-1.58

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.9

FCFYN/A

OCF(TTM)-0.9

OCFYN/A

SpS0.3

BVpS6.24

TBVpS6.22

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-15.45%
ROE	-25.31%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-14.69%

ROA(5y)-9.92%

ROE(3y)-26.18%

ROE(5y)-20.06%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.03

Health

		Industry Rank	Sector Rank
Debt/Equity	0.57
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.6
Quick Ratio	3.6
Altman-Z	-2

F-Score4

WACC9.33%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)27.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%71.01%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-30.25%

Revenue growth 3Y-46.75%

Revenue growth 5Y-36.34%

Sales Q2Q%10.37%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-9.19%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y46.65%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y46.65%

OCF growth 3YN/A

OCF growth 5YN/A

SERITAGE GROWTH PROP- A / SRG FAQ

What is the ChartMill fundamental rating of SERITAGE GROWTH PROP- A (SRG) stock?

ChartMill assigns a fundamental rating of 1 / 10 to SRG.

Can you provide the valuation status for SERITAGE GROWTH PROP- A?

ChartMill assigns a valuation rating of 0 / 10 to SERITAGE GROWTH PROP- A (SRG). This can be considered as Overvalued.

Can you provide the profitability details for SERITAGE GROWTH PROP- A?

SERITAGE GROWTH PROP- A (SRG) has a profitability rating of 0 / 10.

Can you provide the dividend sustainability for SRG stock?

The dividend rating of SERITAGE GROWTH PROP- A (SRG) is 0 / 10 and the dividend payout ratio is -5.51%.

SERITAGE GROWTH PROP- A (SRG) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SERITAGE GROWTH PROP- A / SRG FAQ

What is the ChartMill fundamental rating of SERITAGE GROWTH PROP- A (SRG) stock?

Can you provide the valuation status for SERITAGE GROWTH PROP- A?

Can you provide the profitability details for SERITAGE GROWTH PROP- A?

Can you provide the dividend sustainability for SRG stock?